Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)

TITAN decreaser diatom heatmap. حسب Brent J. Bellinger (21156150)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( حسب Farrokh Habibzadeh (12256529)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). حسب Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... حسب Elizabeth S. Munroe (21568166)

Stepwise regression models for the C–CO₂ rates at the initial (T₀) and final (T₁₂₀; delta values) conditions of incubations. حسب Daniel Cuevas-Lara (12188972)

الموضوعات:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. حسب Elizabeth S. Munroe (21568166)

Long-term anti-nucleocapsid response by baseline patient characteristics. حسب Elizabeth S. Munroe (21568166)

Cells lacking Cbf11 and/or Mga2 display nutrient-responsive decrease in lipid droplet (LD) content. حسب Anna Marešová (14375187)

Table of values for <i>p.</i> حسب Long Di (9977453)

In the first 15 days of pod fill high temperature over 30∘C decreased marketable yield for both seasons. حسب Miranda Y. Mortlock (20855564)

Area under the curve (AUC) for external validation performance. حسب Junichi Kushioka (12236447)

Polylactic Acid/Polybutylene Adipate Terephthalate-Carbon Nanotube Nanobiocomposites with a Segregated Toughening Morphology Yielding Large Ductility for Biocompatible Materials حسب Utsab Ayan (18552401)

الموضوعات:

AUC surface with respect to regularization parameters <i>λ</i> and . حسب Yangsong He (13909371)

<i>r</i>² values for <i>α</i> relationships. حسب James Cushway (19942288)

The multiple criteria qualitative value-based pricing framework “MARIE” for new clinical status حسب Akina Takami (16407200)

Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. حسب Ryan J. Treves (13527735)